Corrigendum: siRNA carrying an (E)-vinylphosphonate moiety at the 5' end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2 (Nucleic Acids Research (2016) DOI: 10.1093/nar/gkw1171);SiRNA carrying an (E)-vinylphosphonate moiety at the 5' end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2

Nucleic Acids Research

Volumn 45, Issue 6, 2017, Pages 3528-3536

  Elkayam, Elad ^a,b,c   Parmar, Rubina ^d   Brown, Christopher R ^d   Willoughby, Jennifer L ^d   Theile, Christopher S ^d   Manoharan, Muthiah ^d   Joshua Tor, Leemor ^a,b,c  

^a W M Keck Structural Biology Laboratory   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Simons Center for Quantitative Biology   (United States)

^d ALNYLAM PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' VINYLPHOSPHONATE; ARGONAUTE 2 PROTEIN; N ACETYLGALACTOSAMINE; PHOSPHATE BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALBUMIN RECEPTOR; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; GUIDE RNA; PHOSPHONIC ACID DERIVATIVE; TRANSTHYRETIN RECEPTOR; VINYL DERIVATIVE; VINYLPHOSPHONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN STRUCTURE; ANIMAL; BINDING SITE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOLECULAR MODEL; RNA INTERFERENCE;

ANIMALS; ARGONAUTE PROTEINS; BINDING SITES; HUMANS; MICE; MODELS, MOLECULAR; ORGANOPHOSPHONATES; RECEPTORS, ALBUMIN; RNA INTERFERENCE; RNA, GUIDE; RNA, SMALL INTERFERING; VINYL COMPOUNDS;

EID: 85019939992     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw1298     Document Type: Erratum

References (48)

1. Rivas, F.V, Tolia, N.H., Song, J.-J., Aragon, J.P., Liu, J., Hannon, G.J. and Joshua-Tor, L. (2005) Purifed Argonaute2 and an siRNA form recombinant human RISC. Nat. Struct. Mol Biol, 12, 340-349.
2. Wee, L.M., Flores-Jasso, C.F., Salomon, W.E. and Zamore, P.D. (2012) Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell, 151, 1055-1067.
3. Frank, F., Fabian, M.R., Stepinski, J., Jemielity, J., Darzynkiewicz, E., Sonenberg, N. and Nagar, B. (2011) Structural analysis of 5'-mRNA-cap interactions with the human AGO2 MID domain. EMBO Rep., 12, 415-420.
4. Boland, A., Tritschler, F, Heimstadt, S., Izaurralde, E. and Weichenrieder, O. (2010) Crystal structure and ligand binding of the MID domain of a eukaryotic Argonaute protein. EMBO Rep. 11, 522-527.
5. Boland, A., Huntzinger, E., Schmidt, S., Izaurralde, E. and Weichenrieder, O. (2011) Crystal structure of the MID-PIWI lobe of a eukaryotic Argonaute protein. Proc. Natl Acad. Sci. U.S.A., 108, 10466-10471.
6. Sehgal, A., Barros, S., Ivanciu, L., Cooley, B., Qin, J., Racie, T., Hettinger, J., Carioto, M., Jiang, Y, Brodsky, J. et al. (2015) An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. Nat. Med., 21, 492-497.
7. Chan, A., Liebow, A., Yasuda, M., Gan, L., Racie, T., Maier, M., Kuchimanchi, S., Foster, D., Milstein, S., Charisse, K. et al. (2015) Preclinical development of a subcutaneous ALAS1 RNAi therapeutic for treatment of hepatic porphyrias using circulating RNA quantifcation. Mol. Ther. Nucleic Acids, 4, e263.
8. Nair, J.K., Willoughby, J.L.S., Chan, A., Charisse, K., Alam, M.R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel'in, A.V, Milstein, S. et al (2014) Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc, 136, 16958-16961.
9. Prakash, T.P., Lima, W.F., Murray, H.M., Elbashir, S., Cantley, W., Foster, D., Jayaraman, M., Chappell, A.E., Manoharan, M., Swayze, E.E. et al. (2013) Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animals. ACS Chem. Biol, 8, 1402-1406.
10. Parmar, R., Willoughby, J.L.S., Liu, J., Foster, D.J., Brigham, B., Theile, C.S., Charisse, K., Akinc, A., Guidry, E., Pei, Y. et al. (2016) 5'-(E)-Vinylphosphonate: a stable phosphate mimic can improve the RNAi activity of siRNA-GalNAc conjugates. ChemBioChem, 17, 985-989.
11. Heydrick, S.J., Lardeux, B.R. and Mortimore, G.E. (1991) Uptake and degradation of cytoplasmic RNA by hepatic lysosomes. Quantitative relationship to RNA turnover. J. Biol. Chem., 266, 8790-8796.
12. Lima, W.F., Prakash, T.P, Murray, H.M., Kinberger, GA., Li, W., Chappell, A.E., Li, C.S., Murray, S.F., Gaus, H., Seth, PP et al. (2012) Single-stranded siRNAs activate RNAi in animals. Cell, 150, 883-894.
13. Yu, D., Pendergraff, H., Liu, J., Kordasiewicz, H.B., Cleveland, D.W., Swayze, E.E., Lima, W.F, Crooke, S.T., Prakash, T.P and Corey, D.R. (2012) Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell, 150, 895-908.
14. Hu, J., Liu, J., Narayanannair, K.J., Lackey, J.G, Kuchimanchi, S., Rajeev, K.G, Manoharan, M., Swayze, E.E., Lima, W.F., Prakash, T.P et al. (2014) Allele-selective inhibition of mutant Atrophin-1 expression by duplex and single-stranded RNAs. Biochemistry, 53, 4510-4518.
15. Prakash, T.P, Lima, W.F., Murray, H.M., Li, W., Kinberger, G.A., Chappell, A.E., Gaus, H., Seth, PP, Bhat, B., Crooke, S.T. et al. (2015) Identifcation of metabolically stable 5'-phosphate analogs that support single-stranded siRNA activity. Nucleic Acids Res., 43, 2993-3011.
16. Hampton, A., Kappler, F. and Perini, F. (1976) Evidence for the conformation about the C(5')-O(5') bond of AMP complexed to AMP kinase: substrate properties of a vinyl phosphonate analog of AMP. Bioorg. Chem., 5, 31-35.
17. Harborth, J., Elbashir, S.M., Vandenburgh, K., Manninga, H., Scaringe, S.A., Weber, K. and Tuschl, T. (2003) Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev., 13, 83-105.
18. Manoharan, M. (2004) RNA interference and chemically modifed small interfering RNAs. Curr. Opin. Chem. Biol., 8, 570-579.
19. Allerson, C.R., Siouf, N, Jarres, R., Prakash, T.P, Naik, N, Berdeja, A., Wanders, L., Griffey, R.H., Swayze, E.E. and Bhat, B. (2005) Fully 2'-modifed oligonucleotide duplexes with improved in vitro potency and stability compared to unmodifed small interfering RNA. J. Med. Chem., 48, 901-904.
20. Prakash, T.P, Allerson, C.R., Dande, P, Vickers, T.A., Siouf, N, Jarres, R., Baker, B.F, Swayze, E.E., Griffey, R.H. and Bhat, B. (2005) Positional effect of chemical modifcations on short interference RNA activity in mammalian cells. J. Med. Chem., 48, 4247-4253.
21. Bumcrot, D., Manoharan, M., Koteliansky, V. and Sah, D.W.Y. (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol, 2, 711-719.
22. Watts, J.K., Deleavey, GF and Damha, M.J. (2008) Chemically modifed siRNA: tools and applications. Drug Discov. Today, 13, 842-855.
23. Elkayam, E., Kuhn, C.-D., Tocilj, A., Haase, A.D., Greene, E.M., Hannon, GJ. and Joshua-Tor, L. (2012) The structure of human argonaute-2 in complex with miR-20a. Cell, 150, 100-110.
24. Vonrhein, C, Flensburg, C, Keller, P, Sharff, A., Smart, O., Paciorek, W., Womack, T. and Bricogne, G (2011) Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol Crystallogr, 67, 293-302.
25. McCoy, A.J. (2007) Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr. D Biol. Crystallogr, 63, 32-41.
26. Adams, PD., Afonine, PV, Bunkoczi, G, Chen, V.B., Davis, I.W., Echols, N, Headd, J.J., Hung, L.-W., Kapral, GJ., Grosse-Kunstleve, R.W. et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr, 66, 213-221.
27. Emsley, P, Lohkamp, B., Scott, W.G and Cowtan, K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr., 66, 486-501.
28. Faehnle, CR., Elkayam, E., Haase, A.D., Hannon, GJ. and Joshua-Tor, L. (2013) The making of a slicer: activation of human Argonaute-1. Cell Rep., 3, 1901-1909.
29. Pei, Y, Hancock, PJ., Zhang, H., Bartz, R., Cherrin, C, Innocent, N, Pomerantz, CJ., Seitzer, J., Koser, M.L., Abrams, M.T et al. (2010) Quantitative evaluation of siRNA delivery in vivo. RNA, 16, 2553-2563.
30. Chen, C (2005) Real-time quantifcation of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 33, e179.
31. Saraiva, M.J., Costa, PP, Birken, S. and Goodman, D.S. (1983) Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans. Assoc. Am. Physicians, 96, 261-270.
32. Schirle, NT, Kinberger, GA., Murray, H.F, Lima, W.F, Prakash, TP and MacRae, I.J. (2016) Structural analysis of human Argonaute-2 bound to a modifed siRNA guide. J. Am. Chem. Soc, 138, 8694-8697.
33. Schirle, NT and MacRae, I.J. (2012) The crystal structure of human Argonaute2. Science, 336, 1037-1040.
34. Nakanishi, K., Ascano, M., Gogakos, T, Ishibe-Murakami, S., Serganov, A.A., Briskin, D., Morozov, P, Tuschl, T and Patel, D.J. (2013) Eukaryote-specifc insertion elements control human ARGONAUTE slicer activity. Cell Rep, 3, 1893-1900.
35. Schirle, NT, Sheu-Gruttadauria, J. and MacRae, I.J. (2014) Structural basis for microRNA targeting. Science, 346, 608-613.
36. Lima, W.F, Wu, H., Nichols, J.G, Sun, H., Murray, H.M. and Crooke, S.T (2009) Binding and cleavage specifcities of human Argonaute2. J. Biol. Chem., 284, 26017-26028.
37. Frank, F, Sonenberg, N and Nagar, B. (2010) Structural basis for 5'-nucleotide base-specifc recognition of guide RNA by human AGO2. Nature, 465, 818-822.
38. Teplova, M., Minasov, G, Tereshko, V, Inamati, GB., Cook, PD., Manoharan, M. and Egli, M. (1999) Crystal structure and improved antisense properties of 2'-O-(2-methoxyethyl)-RNA. Nat. Struct. Mol. Biol, 6, 535-539.
39. Manoharan, M., Akinc, A., Pandey, R.K., Qin, J., Hadwiger, P, John, M., Mills, K., Charisse, K., Maier, M.A., Nechev, L. et al. (2011) Unique gene-silencing and structural properties of 2'-fuoro-modifed siRNAs. Angew. Chem. Int. Ed., 50, 2284-2288.
40. Lubini, P, Zurcher, W. and Egli, M. (1994) Stabilizing effects of the RNA 2'-substituent: crystal structure of an oligodeoxynucleotide duplex containing 2'-O-methylated adenosines. Chem. Biol, 1, 39-45.
41. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, CC (1998) Potent and specifc genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
42. Matranga, C, Tomari, Y, Shin, C, Bartel, D.P and Zamore, P.D. (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell, 123, 607-620.
43. Liu, Q., Rand, TA., Kalidas, S., Du, F, Kim, H.-E., Smith, D.P and Wang, X. (2003) R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science, 301, 1921-1925.
44. Pham, J.W., Pellino, J.L., Lee, YS., Carthew, R.W. and Sontheimer, E.J. (2004) A Dicer-2-dependent 80S complex cleaves targeted mRNAs during RNAi in Drosophila. Cell, 117, 83-94.
45. Iwasaki, S., Kobayashi, M., Yoda, M., Sakaguchi, Y, Katsuma, S., Suzuki, T and Tomari, Y (2010) Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Molecular Cell, 39, 292-299.
46. Iwasaki, S., Sasaki, H.M., Sakaguchi, Y., Suzuki, T., Tadakuma, H. and Tomari, Y. (2015) Defning fundamental steps in the assembly of the Drosophila RNAi enzyme complex. Nature, 521, 533-536.
47. Olejniczak, S.H., La Rocca, G., Gruber, J.J. and Thompson, C.B. (2013) Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc. Natl. Acad. Sci. U. S. A., 110, 157-162.
48. Martinez, N.J. and Gregory, R.I. (2013) Argonaute2 expression is post-transcriptionally coupled to microRNA abundance. RNA, 19, 605-612.